Nanotechnology-based approaches for effective detection of tumor markers: A comprehensive state-of-the-art review
As well-appreciated biomarkers, tumor markers have been spotlighted as reliable tools for
predicting the behavior of different tumors and helping clinicians ascertain the type of …
predicting the behavior of different tumors and helping clinicians ascertain the type of …
[HTML][HTML] Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to …
JM Oh, BC Ahn - Theranostics, 2021 - ncbi.nlm.nih.gov
The advanced, metastatic differentiated thyroid cancers (DTCs) have a poor prognosis
mainly owing to radioactive iodine (RAI) refractoriness caused by decreased expression of …
mainly owing to radioactive iodine (RAI) refractoriness caused by decreased expression of …
Long-term outcome of differentiated thyroid cancer patients—Fifty years of Croatian thyroid disease referral centre experience
Background: Indolent nature but a high incidence of differentiated thyroid cancer (DTC)
remains a challenge for optimizing patient care. Therefore, prognostic factors present …
remains a challenge for optimizing patient care. Therefore, prognostic factors present …
Role of ST6GAL1 in Thyroid Cancers: Insights from Tissue Analysis and Genomic Datasets
Thyroid cancer is the predominant endocrine-related malignancy. ST6 β-galactoside α2, 6-
sialyltransferase 1 (ST6GAL1) has been studied in various types of cancers; however, the …
sialyltransferase 1 (ST6GAL1) has been studied in various types of cancers; however, the …
A novel role of galectin-3 and thyroglobulin in prognosis and differentiation of different stages of thyroid cancer and elucidation of the potential contribution of bcl-2, IL …
Thyroid cancer is among the most prevalent cancers with different types and stages. New
markers are required for the prognosis and diagnosis of the disease. The present study …
markers are required for the prognosis and diagnosis of the disease. The present study …
Is there any association between fluoride exposure and thyroid function modulation? A systematic review
MKM Ferreira, PC Nascimento, LO Bittencourt… - Plos one, 2024 - journals.plos.org
Numerous pre-clinical and observational studies have explored the potential effects of
fluoride (F) at varying concentrations on diverse systems and organs. While some have …
fluoride (F) at varying concentrations on diverse systems and organs. While some have …
A high-sensitivity cfDNA capture enables to detect the BRAF V600E mutation in papillary thyroid carcinoma
Although many efforts have been made to investigate a promising biomarker for the
diagnosis of papillary thyroid cancer (PTC), the currently available biomarkers lack the …
diagnosis of papillary thyroid cancer (PTC), the currently available biomarkers lack the …
Highly sensitive electrochemical immunosensor using a protein-polyvinylidene fluoride nanocomposite for human thyroglobulin
MOS de Moraes, JDP de Moraes, MM da Silva Paula… - …, 2021 - Elsevier
The highly sensitive detection of serum thyroglobulin (Tg) is essential in the post-treatment
follow-up of patients with differentiated thyroid cancer undergoing total or partial …
follow-up of patients with differentiated thyroid cancer undergoing total or partial …
Delayed initial radioiodine adjuvant therapy does affect biochemical response in intermediate-to high-risk differentiated thyroid cancer
F Yu, X Li, Y Ji, J Tan, G Zhang, P Wang… - Frontiers in …, 2021 - frontiersin.org
Background There are no definite recommendations on the optimal time of initiating
radioactive iodine (RAI) therapy for differentiated thyroid cancer (DTC) patients in current …
radioactive iodine (RAI) therapy for differentiated thyroid cancer (DTC) patients in current …
[HTML][HTML] Laboratory evaluation of tumor biomarkers
SM Premnath, M Zubair - StatPearls, 2023 - statpearls.com
Tumor biomarkers are substances synthesized by cancer cells or other body cells in
response to cancer and released into the circulation.[1] Tumor biomarkers vary widely in …
response to cancer and released into the circulation.[1] Tumor biomarkers vary widely in …